Gerding, D N <br/><br/>
Susceptibility of Clostridium difficile isolates from a Phase 2 clinical trial of cadazolid and vancomycin in C. difficile infection.  [electronic resource] 

 -  The Journal of antimicrobial chemotherapy  Jan 2016 
 - 213-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1460-2091 
<br/><br/><label>Standard No.: </label>10.1093/jac/dkv300  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Anti-Bacterial Agents--administration & dosage<br/>Clostridioides difficile--classification<br/>Clostridium Infections--drug therapy<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Male<br/>Microbial Sensitivity Tests<br/>Middle Aged<br/>Oxazolidinones--administration & dosage<br/>Ribotyping<br/>Vancomycin--administration & dosage<br/>Young Adult